Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 15, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	8,084	7,200	8,494	5,597	3,419	502
Market Cap Growth	-1.88%	-15.23%	51.75%	63.72%	580.90%	-
Enterprise Value	3,301	2,500	2,824	5,021	1,886	-326
Last Close Price	11.85	10.09	10.54	7.38	4.94	9.78
PE Ratio	-	-	1.95	-	-	-
PS Ratio	348.12	247.81	259.64	177.52	61.84	21.10
PB Ratio	1.76	1.39	1.32	3.48	1.66	0.24
P/TBV Ratio	1.73	1.54	1.42	5.53	2.06	0.28
EV/Sales Ratio	142.09	86.05	86.33	159.25	34.11	-
Debt / Equity Ratio	0.02	0.02	0.01	0.30	0.14	0.12
Asset Turnover	-	0.01	0.01	0.01	0.02	0.01
Quick Ratio	-	32.71	24.35	6.29	11.21	9.39
Current Ratio	-	33.47	25.24	6.60	11.64	9.99
Return on Equity (ROE)	-	-12.54%	112.87%	-48.46%	-44.82%	-43.17%
Return on Assets (ROA)	-	-10.73%	-10.14%	-20.33%	-20.26%	-11.71%
Return on Capital (ROIC)	-12.53%	-11.52%	-11.34%	-22.80%	-22.54%	-12.91%
Earnings Yield	-6.07%	-2.39%	51.20%	-18.03%	-24.72%	-161.17%
FCF Yield	-	-11.72%	-9.03%	-15.29%	-20.33%	-111.12%
Buyback Yield / Dilution	13.77%	12.71%	-16.59%	-6.43%	-6.30%	-187.64%

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q